Literature DB >> 21826020

Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator.

Yasuhiro Tomii1, Kazunori Toyoda, Takahiro Nakashima, Tomohisa Nezu, Masatoshi Koga, Chiaki Yokota, Kazuyuki Nagatsuka, Kazuo Minematsu.   

Abstract

BACKGROUND AND
PURPOSE: The present study clarifies associations between stroke outcomes after intravenous tissue plasminogen activator (tPA) and blood pressure (BP) as well as heart rate (HR) profiles.
METHODS: We assessed 125 patients with stroke who received tPA within 3 h of onset. We obtained baseline, mean, maximum, minimum, and coefficient of variation values for BP and HR during the initial 24 h. The primary outcome was independence at 3 months corresponding to a modified Rankin Scale score of 2 or less. The secondary outcomes were early neurological improvement at 24 h and intracerebral hemorrhage (ICH) within 36 h.
RESULTS: Among the patients, 64 (51%) achieved independence, 66 (53%) early improvement, and 26 (21%) developed ICH. The 24-h time courses of SBP (P = 0.033), pulse pressure (PP, P = 0.007), and HR (P < 0.001) were lower among patients who reached independence than among those who did not. After multivariate adjustment, 24-h mean levels of SBP (odds ratio 0.69, 95% confidence interval 0.48-0.97, per 10-mmHg increase), PP (0.63, 0.41-0.94), and HR (0.59, 0.42-0.80, per 10-bpm increase) were inversely associated with independence, as were their maximum and minimum values. In particular, mean SBP values were inversely associated with independence at 8-16 and 16-24 h (0.73, 0.54-0.97 and 0.66, 0.47-0.91, respectively), but not at 0-8 h (0.79, 0.57-1.07). Baseline and maximum SBP were inversely associated with early improvement. Maximum and coefficient of variation of SBP were associated with ICH.
CONCLUSION: Lower SBP, PP, and HR values during the initial 24 h after tPA, especially at 8 h thereafter, were associated with independence at 3 months.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21826020     DOI: 10.1097/HJH.0b013e32834a764e

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  3 in total

1.  Association of Elevated Blood Pressure Levels with Outcomes in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.

Authors:  Konark Malhotra; Niaz Ahmed; Angeliki Filippatou; Aristeidis H Katsanos; Nitin Goyal; Konstantinos Tsioufis; Efstathios Manios; Maria Pikilidou; Peter D Schellinger; Anne W Alexandrov; Andrei V Alexandrov; Georgios Tsivgoulis
Journal:  J Stroke       Date:  2019-01-31       Impact factor: 6.967

2.  Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.

Authors:  Kazunori Toyoda; Masatoshi Koga; Yasuyuki Iguchi; Ryo Itabashi; Manabu Inoue; Yasushi Okada; Kuniaki Ogasawara; Akira Tsujino; Yasuhiro Hasegawa; Taketo Hatano; Hiroshi Yamagami; Toru Iwama; Yoshiaki Shiokawa; Yasuo Terayama; Kazuo Minematsu
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-12-05       Impact factor: 1.742

3.  Prognostic significance of early systolic blood pressure variability after endovascular thrombectomy and intravenous thrombolysis in acute ischemic stroke: A systematic review and meta-analysis.

Authors:  Jingcui Qin; Zhijun Zhang
Journal:  Brain Behav       Date:  2020-10-14       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.